Magnesium L-Threonate is a product developed by MIT scientists in 2010. This patented compound has been proven by animal studies to improve working memory, short-term and long-term memory and learning abilities.
The first animal study using Magnesium L-Threonate was published in Neuron in 2010, pointing out that Magnesium L-Threonate can quickly absorbed into the brain, by increasing the “number of functional presynaptic release sites, while reducing their release probability”.Structurally, it reverses certain aspects of brain aging.
Magnesium has long been recognized as an essential mineral for the human body, which can affect more than 300 important physiological functions, such as contraction of muscles,keep the heartbeat, generate energy, activate nerves to send and receive information.
Before reaching this conclusion, the study conducted a baseline cognitive test and performed the first follow-up test 6 weeks later. At 12 weeks, the subjects were randomized to take placebo or 1500 to 2000 grams of Magnesium L-Threonate (depending on body weight) every day, because every day the test will be repeated every 6 weeks and 12 weeks for the following aspects: executive ability, working memory, concentration, and ability to recall short-lived events.
The most “surprising” finding is that Magnesium L-Threonate not only improves the performance of the elderly with cognitive impairment in individual cognitive tests, but also reverses brain aging for more than 9 years. The results of the study revealed four important results of the use of Magnesium L-Threonate: improving the magnesium status in the body. After 12 weeks, the treated group had two changes: the red blood cell magnesium concentration was significantly increased, indicating a higher circulating level of magnesium in the body; urinary magnesium The amount is significant, indicating that a large amount of magnesium has been absorbed.
Improved cognitive ability-visual attention and task switching revealed (in some cases only 6 weeks) the performance speed of executive function and cognitive processing has been accelerated. It is worth noting that in the 6th and 12th weeks, the overall composite score increased significantly compared with the baseline score and the placebo group.
Reduced fluctuations in cognitive ability-cognitive function is sometimes worse than other times is one of the signs that mild cognitive impairment may be forming. The cognitive score of the placebo group has obvious fluctuations, while the changes in the MgT group are mainly positive Nature.
Clinical measurement data that reversed the aging of the brain-this is perhaps the most important finding, which explains how Magnesium L-Threonate continues to age ”Reverse time” in your brain.
Post time: Nov-17-2021